Resideo exec plans 40,000-share sale, worth $776K

RESIDEO TECHNOLOGIES, INC.

Rhea-AI Filing Summary

RESIDEO TECHNOLOGIES, INC. (REZI) is the issuer for which officer Robert Aarnes filed a notice of proposed sale of restricted or control securities under Rule 144. The notice covers a planned sale of 40,000 shares of common stock, expected to be sold on August 25, 2026 on the NYSE through Morgan Stanley Smith Barney LLC, with an indicated aggregate value of $775,772.00. The shares are to be sold in connection with a stock option exercise. The notice also lists prior sales by Aarnes in the past three months.

Key Figures

Planned shares to be sold: 40,000 shares of common stock Aggregate market value of planned sale: $775,772.00 Shares sold on August 21, 2026: 30,000 shares of common stock +3 more

6 metrics

Planned shares to be sold 40,000 shares of common stock Proposed Rule 144 sale related to stock option exercise on August 25, 2026

Aggregate market value of planned sale $775,772.00 Estimated value for 40,000 REZI common shares to be sold on August 25, 2026

Shares sold on August 21, 2026 30,000 shares of common stock Prior sale by Robert Aarnes during the past 3 months

Aggregate value of August 21, 2026 sale $605,070.00 Value of 30,000 REZI common shares sold by Robert Aarnes

Shares sold on August 17, 2026 47,000 shares of common stock Prior sale by Robert Aarnes during the past 3 months

Aggregate value of August 17, 2026 sale $999,741.70 Value of 47,000 REZI common shares sold by Robert Aarnes

Key Terms

Rule 144, Stock Option Exercise, aggregate market value

3 terms

Rule 144 regulatory

"See the definition of "person" in paragraph (a) of Rule 144."

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

Stock Option Exercise financial

"Common | 08/25/2026 | Stock Option Exercise | Issuer"

A stock option exercise is the act of using a previously granted right to buy shares of a company's stock at a specific, predetermined price by paying that price and receiving the shares. It matters to investors because exercising changes who owns the shares (which can dilute existing ownership), can trigger taxable events and shift potential gains or losses, and affects voting power and the company’s outstanding share count—like turning a voucher into an actual product that becomes part of circulating supply.

aggregate market value financial

"Common | Morgan Stanley Smith Barney LLC ... | 40000 | 775772.00"

Aggregate market value is the combined price you would pay to buy all outstanding shares of a company or all companies in a group at current market prices — essentially the sum of each stock’s market capitalization. It matters to investors because it shows the overall size and weight of an investment or sector (like the total cost to buy every piece of a puzzle), helps compare scale across companies or markets, and influences index composition and risk exposure.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does Form 144 filed for REZI by Robert Aarnes disclose?

It discloses that officer Robert Aarnes intends to sell 40,000 shares of Resideo Technologies, Inc. common stock on or about August 25, 2026 on the NYSE, in connection with a stock option exercise, with an indicated aggregate value of $775,772.00.

How many REZI shares does Robert Aarnes plan to sell under this Form 144?

The filing states that 40,000 shares of common stock of Resideo Technologies, Inc. are planned to be sold, related to a stock option exercise and expected to occur on August 25, 2026.

What is the estimated value of the REZI shares to be sold by Robert Aarnes?

The Form 144 indicates an aggregate market value of $775,772.00 for the planned sale of 40,000 REZI common shares through Morgan Stanley Smith Barney LLC.

Which broker is listed for the planned REZI share sale by Robert Aarnes?

The planned sale of 40,000 REZI common shares is to be executed through Morgan Stanley Smith Barney LLC Executive Financial Services, located at 1 New York Plaza, New York, NY.

What REZI stock sales has Robert Aarnes reported in the past three months on this Form 144?

The filing lists prior sales of 30,000 common shares on August 21, 2026 for $605,070.00 and 47,000 common shares on August 17, 2026 for $999,741.70.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/25/2026 - 04:20 PM EDT Accepted by SEC EDGAR 08/25/2026 - 04:20 PM EDT Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001754267
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	RESIDEO TECHNOLOGIES, INC.
SEC File Number	001-38635
Address of Issuer	16100 N. 71st Street, Suite 450, Scottsdale ARIZONA 85254
Phone	(480) 573-5340
Name of Person for Whose Account the Securities are To Be Sold	ROBERT AARNES
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	40000	775772.00	151847378	08/25/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	08/25/2026	Stock Option Exercise	Issuer			40000	08/25/2026	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
ROBERT AARNES 16100 N. 71st Street, Suite 450, Scottsdale AZ 85254	Common	08/21/2026	30000	605070.00
ROBERT AARNES 16100 N. 71st Street, Suite 450, Scottsdale AZ 85254	Common	08/17/2026	47000	999741.70

144: Remarks and Signature

Remarks
Date of Notice	08/25/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Robert B Aarnes
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)